하이드로겔 드레싱 시장 : 시장 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of hydrogel dressing Market

The global hydrogel dressing market size was valued at USD 829.0 million in 2025 and is projected to grow from USD 870.07 million in 2026 to USD 1,371.79 million by 2034, registering a CAGR of 5.90% during the forecast period (2026-2034). North America dominated the market with a 40.00% share in 2025, supported by rising chronic wound prevalence and strong healthcare spending.

Hydrogel dressings consist of nearly 90% water combined with insoluble hydrophilic polymers, creating a moist and warm environment that promotes autolytic debridement and accelerates wound healing. These dressings are widely used for diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and surgical wounds. According to the Journal of the American Medical Association (November 2023), diabetic foot ulcers affect around 1.6 million individuals annually in the U.S. and 18.6 million globally, significantly driving product demand.

The COVID-19 pandemic negatively impacted the market in 2020 due to reduced patient visits and temporary closure of wound care departments. However, revenues recovered in 2021 and 2022 as healthcare services resumed, normalizing market growth.

Market Dynamics

Market Drivers

Rising Prevalence of Chronic and Acute Wounds

The growing global burden of diabetic foot ulcers, pressure injuries, and surgical site infections (SSI) is a key growth driver. Surgical wounds contribute significantly to healthcare mortality and costs. Increasing infection rates and prolonged healing durations have led to higher demand for advanced wound care solutions, including hydrogel dressings.

Advantages of Hydrogel Dressings

Hydrogel dressings maintain moisture, support tissue regeneration, and remove necrotic tissue through autolysis. They can be used with topical medications and are suitable for multiple wound types. These benefits have increased physician preference and product adoption across hospitals and homecare settings.

Market Trends

Increasing R&D on Novel Hydrogels

Ongoing research focuses on developing innovative hydrogel formulations using natural sources such as plant extracts, animal tissues, and extracellular matrices. Companies are investing in clinical trials to introduce advanced hydrogel products. For example, Remedor Biomed Ltd. is conducting trials on erythropoietin-based hydrogels for diabetic foot ulcers.

Technologies such as 3D printing and nanotechnology are enabling the development of advanced hydrogel dressings with enhanced antimicrobial and regenerative properties, which are expected to boost long-term market growth.

Restraining Factors

High Treatment Costs and Limited Reimbursement

The high cost of chronic wound care remains a major barrier. For example, the NHS spends approximately USD 6.48 billion annually on wound management. Limited reimbursement policies and high out-of-pocket expenses restrict product adoption, particularly in developing countries. These financial challenges may limit market expansion during the forecast period.

Segmentation Analysis

By Product

The market is segmented into amorphous, impregnated, and sheet dressings.

The amorphous segment dominated in 2026 with a 61.87% share, owing to its superior healing efficiency and ease of application. These dressings are widely preferred for treating ulcers and chronic wounds.

Impregnated dressings are projected to grow moderately due to increasing demand for products such as AquaSite Hydrogel and SOLOSITE. Sheet dressings accounted for a considerable share in recent years, supported by rising awareness of moisture-balancing wound care solutions.

By Material

Based on material, the market is divided into natural, synthetic, and semi-synthetic.

The synthetic segment led the market in 2026 with a 53.50% share, driven by effective formulations made from polyethylene glycol and polyacrylic acid. These materials create optimal wound-healing environments. The natural segment is expected to grow at a faster pace due to increasing preference for biologically derived materials.

By Application

The market is categorized into diabetic foot ulcers, pressure ulcers, venous leg ulcers, burn injuries, and others.

The others segment (including surgical and traumatic wounds) dominated in 2024, supported by rising SSI incidence globally. Meanwhile, the diabetic foot ulcer segment accounted for 25.43% share in 2026, driven by the growing diabetic population and prolonged healing requirements. Venous leg ulcers and pressure ulcers are expected to grow steadily through 2034.

By End-user

The market is segmented into hospitals & clinics, homecare settings, and others.

The hospitals & clinics segment dominated in 2026 with a 61.35% share, due to high patient inflow and better reimbursement structures. Homecare settings are anticipated to witness the fastest growth, supported by rising geriatric populations and preference for at-home wound management.

Regional Insights

North America

North America accounted for USD 331.43 million in 2025, maintaining leadership due to high chronic wound prevalence and strong healthcare investments. The U.S. market is projected to reach USD 310.2 million in 2026.

Europe

Europe holds the second-largest share, supported by cost-reduction initiatives and improved wound management programs. The Germany market is projected at USD 96 million in 2026, while the UK market is projected at USD 49.5 million in 2026.

Asia Pacific

Asia Pacific is expected to witness the fastest growth. The China market is projected at USD 45.7 million in 2026, India at USD 37.4 million, and Japan at USD 29.3 million, driven by a large diabetic population and increasing healthcare awareness.

Latin America and the Middle East & Africa are expected to grow steadily with improving healthcare access.

Competitive Landscape

The market is semi-consolidated with key players including 3M, Smith+Nephew, ConvaTec Group, Coloplast A/S, Integra LifeSciences, B. Braun SE, and Essity Aktiebolag. Companies focus on partnerships, acquisitions, and product innovation to expand global presence.

Notable developments include:

• December 2023: Lavior Pharma launched diabetic hydrogel wound dressing at Walmart (U.S.).
• June 2023: University of Waterloo researchers developed a novel hydrogel material.
• May 2019: 3M acquired Acelity Inc. to strengthen wound care portfolio.

Conclusion

The global hydrogel dressing market is projected to grow steadily from USD 829.0 million in 2025 to USD 870.07 million in 2026, reaching USD 1,371.79 million by 2034, at a CAGR of 5.90%. Rising chronic wound prevalence, technological advancements, and expanding geriatric populations are key growth drivers. While high treatment costs and reimbursement limitations pose challenges, continuous innovation and growing healthcare investments are expected to sustain long-term market expansion worldwide.

Segmentation By Product

• Amorphous
• Impregnated Dressings
• Sheet Dressings

By Material

• Natural
• Synthetic
• Semi-synthetic

By Application

• Diabetic Foot Ulcer
• Pressure Ulcer
• Venous Leg Ulcer
• Burn Wounds
• Others

By End-user

• Hospitals & Clinics
• Homecare Settings
• Others

By Region

• North America (By Product, Material, Application, End-user, and Country)
  • U.S. (By Product)
  • Canada (By Product)
• Europe (By Product, Material, Application, End-user, and Country/Sub-Region)
  • U.K. (By Product)
  • Germany (By Product)
  • France (By Product)
  • Italy (By Product)
  • Spain (By Product)
  • Rest of Europe (By Product)
• Asia Pacific (By Product, Material, Application, End-user, and Country/Sub-Region)
  • China (By Product)
  • Japan (By Product)
  • India (By Product)
  • Australia (By Product)
  • Rest of Asia Pacific (By Product)
• Rest of the World (By Product, Material, Application, and End-user)

Table of Content

1. Introduction

• 1.1. Market Scope
• 1.2. Market Segmentation
• 1.3. Market Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence/Incidence of Key Diseases, By Key Countries/ Regions, 2025
• 4.2. Economic Cost Burden, Wound Care, Key Countries, 2025/2025
• 4.3. Overview of Technological Advancements in Hydrogel Dressings
• 4.4. Product Mapping of Key Hydrogel Dressings, By Key Companies
• 4.5. New Product Launches, By Key Players
• 4.6. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
• 4.7. Impact of COVID-19 on the Global Hydrogel Dressing Market

5. Global Hydrogel Dressing Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Amorphous
  • 5.1.2. Impregnated Dressings
  • 5.1.3. Sheet Dressings
• 5.2. Market Analysis, Insights and Forecast - By Material
  • 5.2.1. Natural
  • 5.2.2. Synthetic
  • 5.2.3. Semi-synthetic
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Diabetic Foot Ulcer
  • 5.3.2. Pressure Ulcer
  • 5.3.3. Venous Leg Ulcer
  • 5.3.4. Burn Wounds
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & Clinics
  • 5.4.2. Homecare Settings
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Geography
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Rest of the World

6. North America Hydrogel Dressing Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Amorphous
  • 6.1.2. Impregnated Dressings
  • 6.1.3. Sheet Dressings
• 6.2. Market Analysis, Insights and Forecast - By Material
  • 6.2.1. Natural
  • 6.2.2. Synthetic
  • 6.2.3. Semi-synthetic
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Diabetic Foot Ulcer
  • 6.3.2. Pressure Ulcer
  • 6.3.3. Venous Leg Ulcer
  • 6.3.4. Burn Wounds
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & Clinics
  • 6.4.2. Homecare Settings
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Product
  • 6.5.2. Canada
    • 6.5.2.1. By Product

7. Europe Hydrogel Dressing Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Amorphous
  • 7.1.2. Impregnated Dressings
  • 7.1.3. Sheet Dressings
• 7.2. Market Analysis, Insights and Forecast - By Material
  • 7.2.1. Natural
  • 7.2.2. Synthetic
  • 7.2.3. Semi-synthetic
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Diabetic Foot Ulcer
  • 7.3.2. Pressure Ulcer
  • 7.3.3. Venous Leg Ulcer
  • 7.3.4. Burn Wounds
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Homecare Settings
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K
    • 7.5.1.1. By Product
  • 7.5.2. Germany
    • 7.5.2.1. By Product
  • 7.5.3. France
    • 7.5.3.1. By Product
  • 7.5.4. Spain
    • 7.5.4.1. By Product
  • 7.5.5. Italy
    • 7.5.5.1. By Product
  • 7.5.6. Rest of Europe
    • 7.5.6.1. By Product

8. Asia Pacific Hydrogel Dressing Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Amorphous
  • 8.1.2. Impregnated Dressings
  • 8.1.3. Sheet Dressings
• 8.2. Market Analysis, Insights and Forecast - By Material
  • 8.2.1. Natural
  • 8.2.2. Synthetic
  • 8.2.3. Semi-synthetic
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Diabetic Foot Ulcer
  • 8.3.2. Pressure Ulcer
  • 8.3.3. Venous Leg Ulcer
  • 8.3.4. Burn Wounds
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & Clinics
  • 8.4.2. Homecare Settings
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Product
  • 8.5.2. China
    • 8.5.2.1. By Product
  • 8.5.3. India
    • 8.5.3.1. By Product
  • 8.5.4. Australia
    • 8.5.4.1. By Product
  • 8.5.5. Rest of Asia Pacific
    • 8.5.5.1. By Product

9. Rest of the World Hydrogel Dressing Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Amorphous
  • 9.1.2. Impregnated Dressings
  • 9.1.3. Sheet Dressings
• 9.2. Market Analysis, Insights and Forecast - By Material
  • 9.2.1. Natural
  • 9.2.2. Synthetic
  • 9.2.3. Semi-synthetic
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Diabetic Foot Ulcer
  • 9.3.2. Pressure Ulcer
  • 9.3.3. Venous Leg Ulcer
  • 9.3.4. Burn Wounds
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & Clinics
  • 9.4.2. Homecare Settings
  • 9.4.3. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. Coloplast A/S
    • 10.2.1.1. Overview
    • 10.2.1.2. Products
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. Smith+Nephew
    • 10.2.2.1. Overview
    • 10.2.2.2. Products
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. 3M
    • 10.2.3.1. Overview
    • 10.2.3.2. Products
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. Convatec Inc.
    • 10.2.4.1. Overview
    • 10.2.4.2. Products
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. Integra LifeSciences
    • 10.2.5.1. Overview
    • 10.2.5.2. Products
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. B. Braun SE
    • 10.2.6.1. Overview
    • 10.2.6.2. Products
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. Essity Aktiebolag (publ)
    • 10.2.7.1. Overview
    • 10.2.7.2. Products
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)